Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Adient Medical

Adient Medical
2012 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$3.5M LATEST DEAL AMOUNT
13 INVESTORS
Description

Developer of absorbable medical devices designed to prevent pulmonary embolism. The company's medical devices include an absorbable vascular filter with the premise that implants safe during their useful lifetime and then simply vanishes without intervention, alleviating costly removal procedures and downstream complications, enabling users to protect from a pulmonary embolism.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Primary Office
  • 12234 Shadow Creek Parkway
  • Building 8, Suite 106
  • Pearland, TX 77584-1566
  • United States

+1 (281) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Adient Medical’s full profile, request a free trial.

Adient Medical Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 24-Nov-2017 $3.5M 00.000 Completed Product Development
8. Grant 15-Apr-2017 000 00.000 Completed Pre-Clinical Trials
7. Later Stage VC (Series C) 01-Aug-2016 00.00 00.000 0000 Completed Startup
6. Accelerator/Incubator 13-Jul-2016 0000 00.000 Completed Startup
5. Early Stage VC (Series B) 11-Sep-2015 00.00 00.000 0000 Completed Startup
4. Grant 01-Apr-2015 00000 00000 Completed Startup
3. Grant 01-Apr-2015 00.000 00000 Completed Startup
2. Accelerator/Incubator 09-Mar-2015 $360K 00.00 Completed Startup
1. Angel (individual) 05-Sep-2013 $360K $360K 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Adient Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C 000,000 00.000000 00 00.00 00.00 00 00.00 00
Series B 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A-2 300,000 $0.000100 8% $1 $1 1x $1 4.75%
Series A 200,000 $0.000100 8% $1 $1 1x $1 5.94%
To view this company’s complete Cap Table, request access »

Adient Medical Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
00000000 000000 Corporation Dublin, OH 00000 0000
To view this company’s complete list of competitors, request access »

Adient Medical Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Broadview Ventures Venture Capital Minority 000 0000 000000 0
Grant Park Ventures Venture Capital Minority 000 0000 000000 0
JF2 Capital Venture Capital Minority 000 0000 000000 0
National Heart, Lung and Blood Institute Government 000 0000 000000 0
Green Park & Golf Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »

Adient Medical Executive Team (1)

Name Title Board
Seat
Contact
Info
Mitchell Eggers Ph.D Founder, Owner, Chief Executive Officer, President & Board Member

Adient Medical Board Members (4)

Name Representing Role Since Contact
Info
Maria Berkman MD Broadview Ventures Board Member 000 0000
Michael Hogan Ph.D Adient Medical Board Member 000 0000
Mitchell Eggers Ph.D Adient Medical Founder, Owner, Chief Executive Officer, President & Board Member 000 0000
Robert Tucci Texas Halo Fund Board Member 000 0000